Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-10-16
1998-12-01
Patterson, Jr., Charles L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 21, 530303, 530350, 530412, A61K 3828, A61K 3800, C07K 500, C07K 100
Patent
active
058438874
ABSTRACT:
Compositions comprising intrinsic factor (IF), and in particular, compositions comprising substantially pure intrinsic factor (IF) and a polypeptide wherein said composition is substantially free of R protein; a method of delivering a composition to the portal and/or lymphatic circulation system of a host; and a method of producing the above-described composition.
REFERENCES:
patent: 4279886 (1981-07-01), Allen
patent: 4945083 (1990-07-01), Jansen, Jr.
patent: 5227311 (1993-07-01), Kuemmerle et al.
patent: 5338669 (1994-08-01), Gillies
patent: 5350674 (1994-09-01), Boenisch et al.
patent: 5428023 (1995-06-01), Russell-Jones et al.
patent: 5449720 (1995-09-01), Russell-Jones et al.
M. Saffran et al., "A New Approach to the Oral Administration of Insulin and other Peptide Drugs", Science. vol. 233, pp. 1081-1084 (Sep. 5, 1986).
D. Shah et al., "Transferrin Receptor Mediated Delivery of Insulin-Transferrin Conjugate in CACO-2 Cells", Pharmaceutical Research. vol. 11, No. 10, p. S-7 (Oct. 1994).
Batt, R.M. and Horadagoda, N.U., "Gastric and pancrestic intrinsic factor-mediated absorption of cobalamin in the dog," Am. J. Physiol. 257:G344-G349 (1989).
Davis et al., "Type 1 diatetes and latent pernicious anaemia," Med. J. Australia 156: 160-162 (1992).
Hewitt et al., "Human Gastric Intrinsic Factor: Characterization of cDNA and Genomic Clones and Localization to Human Chromsome 11," Genomics 10432-440 (1991).
Jespersen et al., "Neurophysiological Variables and Fibrinlysis in Insulin-Dependent Diabetes Treated with an Aldose Reductase Inhibitor or Placebo," Haemostasis 16:453-457 (1986).
Johnston et al., "Genomic Structure and Mapping of the Chromosomal Gene for Transcobalamin I (TCN 1): Comparison to Human Intrinsic Factor," Genomics 12(3):459-464 (1992).
Johnston et al., Errata for Genomics 12(3):459-464 (1992), Genomics 14:208 (1992).
Sigma Chemical Company, Catalog for Biochemicals, Organic Compounds for Research and Diagnostic Reagents, pp. 583 (1995).
Bourland, deceased Emile
Petit Serge
Allied Medical Research Associates
Hobbs Lisa J.
Patterson Jr. Charles L.
LandOfFree
Compositions for delivery of polypeptides, and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for delivery of polypeptides, and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for delivery of polypeptides, and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2395625